Browsing by Subject "11 Beta hydroxysteroid dehydrogenase inhibitors, metabolic syndrome, glucocorticoids, obesity, type 2 diabetes."
Now showing items 1-1 of 1
-
Role of 11beta-hydroxysteroid Dehydrogenase Inhibitors in Metabolic Syndrome and its Expansion in other Therapeutic Options
(Sebha University, 2012)The metabolic syndrome is a constellation of interrelated metabolic risk factors that appear to promote the development of diabetes and cardiovascular disease. These risk factors include abdominal obesity, insulin resistance, ...